Pathological complete response after neoadjuvant cyclin-dependent kinase 4/6 inhibitor and neoadjuvant endocrine therapy in locally advanced hormone receptor-positive breast cancer (A. Mahajan, S. K. D. Majumdar, S. K. Barik, D. Kumar Das, D. K. Parida, R. Patnayak, & M. R. Baisakh, Trans.). (2024). Indian Journal of Case Reports, 10(10), 322-324. https://doi.org/10.32677/ijcr.v10i10.4727